Siltartoxatug - Zhuhai Trinomab Pharmaceutical
Alternative Names: Sintetol; TNM-002; TT-069Latest Information Update: 05 Aug 2025
At a glance
- Originator Trinomab Biotech
- Developer Zhuhai Trinomab Pharmaceutical
- Class Antibacterials; Monoclonal antibodies
- Mechanism of Action Tetanus toxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Tetanus